Leah H Biller

9PUBLICATIONS
103CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 13, 2026
A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.

Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun

|Oct 11, 2025
Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy Era.

Asaf Maoz, Leah Biller, Marios Giannakis

|Sep 02, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.

Rishi Surana, Micaela Morgado, Ashwin Somasundaram

|Jan 08, 2025
Comparison of PREMM5 and PREMMplus Risk Assessment Models to Identify Lynch Syndrome.

Leah H Biller, Kate Mittendorf, Miki Horiguchi

|Jul 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.

Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler

|Jun 28, 2024
Experience and Needs of Patients With Young-Onset Colorectal Cancer and Their Caregivers: A Qualitative Study.

Kalen M Fletcher, Anna Revette, Andrea Enzinger

Pageof 2

Frequent Collaborators

6 joint publications

Matthew B Yurgelun

5 joint publications

Kimmie Ng

5 joint publications

Douglas Rubinson

4 joint publications

Brandon M Huffman